Abivax SA (Euronext Paris: ABVX.PA) closed at €99.95, -0.4%, on 2026-08-27, with a market cap of $8.1B as of 2026-08-26, a return on equity of -135.6%, a net margin of -7354.5% and 3-year sales growth of -0.1%. Institutional ownership, earnings history and filed financials are on the tabs below.
Fewer than 4 quarters available; TTM falls back to the latest annual figure.
Some figures named '(TTM)' on this payload are the latest FISCAL YEAR, not a trailing twelve months — ebitda_ttm, eps_ttm, fcf_ttm, net_income_ttm, owner_earnings_ttm, revenue_ttm (fiscal year ended 2025-12-31). No four consecutive quarters could be summed for them — for an IFRS 20-F filer that is every income-statement line (no quarterly income statement is tagged to EDGAR at all); for a US filer it is usually one line the quarterly tagging skips. Each field's own basis is on field_basis.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
P/E (FY)
—
P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
−135.6%
−149.0%
no band (52 mo · 5 distinct)
—
—
−36.9%
52 · 5
ROIC (FY)
—
no reconstructed observations for this name and metric.
−7354.5%
−1415.7%
no band (52 mo · 5 distinct)
—
—
−21.3%
52 · 5
98.6%
22.8%
96th
+3.38σ
5.1%
124 · 124
EPS Growth 3Y (FY)
—
P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
−0.1%
—
no band (16 mo · 2 distinct)
—
—
9.0%
16 · 2
Market Cap
$8.13B
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
ROE (point-in-time)Health Care median, same monthshaded = own p10–p90 · dashed = own median · right-edge tick = today
shown for reference only — the reconstructed distribution did not clear the band gate, so no rank is quoted.
Multiple-implied price ladder · Full
Filed earnings only.
no P/E ladder — P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Ladder not drawn for this name — the reason is above.ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
Industry structureindustry pool pending for ABVX.PA
This company's industry pool year publishes once its group is tagged, its annual revenue is stored and the newest year clears the filing-alignment guard. A coverage gap, never a statement about the company.
